December 15, 2019 2:36pm

Rumors have it, China and the U.S. agreed to a so-called phase one trade deal in principle while the U.K.’s ruling Conservative Party has won a commanding majority in the general election

Pre-open indications:  the oversold will become the overbought that then will be sold into

Don’t get comfortable, yesterday’s market’s close impacts today, Friday; if you were a subscriber … you would understand why!

 

We crave explanations because they give us an illusion of control

 

Dow futures are UP +0.28% (+79 points), S&P futures are UP +0.24% (+9 points) and NASDAQ futures are UP +0.35% (+30 points)

 

U.S. stock index futures were higher, as it is rumored that the world’s two largest economies neared the signing of a so-called “phase one” trade deal;

European stocks surged after news that the U.S. and China have reached a phase one trade deal in principle, while the U.K.’s ruling Conservative Party has won a commanding majority in the general election with the pan-European Stoxx 600 jumping +1.5% after the opening bell.

Asia Pacific markets jumped following news that Washington and Beijing have agreed to a phase one trade deal in principle as the MSCI Asia ex-Japan index jumped +1.61% higher.

 

Data Docket: retail sales for November, core retail sales (excluding autos) for November and import prices for November will all be released at 8:30 a.m. ET. Business inventories for October will follow slightly later in the session.

 

Henry’omics:

As part of the deal “rumors”, the U.S. would scrap additional levies set to take effect on Sunday. The U.S. also proposed cutting tariffs on $360 billion in Chinese goods by up to 50%. President Trump was focused on how much in U.S. agricultural products China would purchase.

Futures also (after China deal rumors) moved after exit polls showed the U.K.’s Conservative party winning a big majority in Parliament, giving Prime Minister Boris Johnson a clear path to move forward with his Brexit plans.

 

Stay the course until your portfolio ... can't !

 

Thursday night’s post’s title:  “investors are skeptical as the cell and gene therapy sector ends the month and year; share pricing is like following the bouncing ball along utilizing the XBI as an indicator.”

  • The NASDAQ closed UP +63.27 points (+0.73%);
  • The IBB closed up +0.81% while the XBI closed up +0.57%
  • The range of the 27 upside was +0.46% (SGMO) to +7.31% (KOOL) while the 14 downside ranged from -0.12% (BOLD) to -14.92% (BLCM); 
  • 9 out of the 27 upside had higher than the 3 month average volume;
  • 10 out of the 14 downside had higher than the 3 month average volume;

Review the content of Q4’s market:

  • December register 4 negative and 5 positive closes … so far
  • November registered 1 holiday, 12 positive and 8 negative close;
  • October registered 10 positive, 1 neutral and 14 negative closes;

 

Companies in my headlights – It’s your decision; I provide an idea and context:

Pre-open indications: BUT – BLUE, ONCE and GBT

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.